Challenges with advanced therapy medicinal products and how to meet them

Christian K Schneider, Paula Salmikangas, Bernd Jilma, Bruno Flamion, Lyubina Racheva Todorova, Anna Paphitou, Ivana Haunerova, Toivo Maimets, Jean-Hugues Trouvin, Egbert Flory, Asterios Tsiftsoglou, Balázs Sarkadi, Kolbeinn Gudmundsson, Maura O'Donovan, Giovanni Migliaccio, Jānis Ancāns, Romaldas Maciulaitis, Jean-Louis Robert, Anthony Samuel, Johannes H OvelgönneMarit Hystad, Andrzej Mariusz Fal, Beatriz Silva Lima, Anca Stela Moraru, Peter Turcáni, Robert Zorec, Sol Ruiz, Lennart Akerblom, Gopalan Narayanan, Alastair Kent, Fabrizia Bignami, J George Dickson, Dietger Niederwieser, María-Angeles Figuerola-Santos, Ilona G Reischl, Claire Beuneu, Rosen Georgiev, Maria Vassiliou, Alena Pychova, Mette Clausen, Taina Methuen, Sophie Lucas, Martina Schüssler-Lenz, Vasilios Kokkas, Zsuzsanna Buzás, Niall MacAleenan, Maria Cristina Galli, Aija Linē, Jolanta Gulbinovic, Guy Berchem, Committee for Advanced Therapies (CAT)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)195-201
Number of pages7
JournalNature Reviews. Drug Discovery
Volume9
Issue number3
DOIs
Publication statusPublished - 2010

Keywords

  • European Union
  • Gene Therapy
  • Government Regulation
  • Humans
  • Stem Cell Transplantation
  • Tissue Engineering

Cite this